Health claim
“BPH complicates the diagnosis and treatment of prostate cancer.”
Claim checked — strong evidenceHigh riskcancer
Evidence Summary
Multiple well-designed studies consistently support this claim.
Benign prostatic hyperplasia often raises PSA levels and causes urinary symptoms that can mask prostate cancer, making diagnosis more challenging and influencing treatment planning.
Extracted from
How BPH Complicates Treatment for Prostate Cancer | Mark Scholz, MD | PCRIProstate Cancer Research Institute
The video explains how benign prostatic hyperplasia (BPH) can raise PSA levels and complicate the diagnosis and treatment of prostate cancer, emphasizing the need for careful clinical assessment.
Watch breakdown →